Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuropeptide Y mitigates neuropathology and motor deficits in mouse models of Machado–Joseph disease
Joana Duarte‐Neves, Nélio Gonçalves, Janete Cunha‐Santos, et al.
Human Molecular Genetics (2015) Vol. 24, Iss. 19, pp. 5451-5463
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9
Joana Rajão‐Saraiva, Rui Jorge Nobre, Luís Pereira de Almeida
Journal of Controlled Release (2016) Vol. 241, pp. 94-109
Closed Access | Times Cited: 181
Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases
Joana Duarte‐Neves, Luís Pereira de Almeida, Cláudia Cavadas
Neurobiology of Disease (2016) Vol. 95, pp. 210-224
Closed Access | Times Cited: 110
Machado-Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy
Carlos A. Matos, Luís Pereira de Almeida, Clévio Nóbrega
Journal of Neurochemistry (2018) Vol. 148, Iss. 1, pp. 8-28
Open Access | Times Cited: 109
Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways
Melissa Ingram, Emily A.L. Wozniak, Lisa Duvick, et al.
Neuron (2016) Vol. 89, Iss. 6, pp. 1194-1207
Open Access | Times Cited: 98
Recent advances in the mechanisms of neuroinflammation and their roles in neurodegeneration
Rituraj Niranjan
Neurochemistry International (2018) Vol. 120, pp. 13-20
Closed Access | Times Cited: 95
Roles of Neuropeptide Y in Neurodegenerative and Neuroimmune Diseases
Chunrong Li, Xiujuan Wu, Shan Liu, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 86
Going Too Far Is the Same as Falling Short†: Kinesin-3 Family Members in Hereditary Spastic Paraplegia
Dominik R. Gabrych, Victor Lau, Shinsuke Niwa, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 67
Rhes travels from cell to cell and transports Huntington disease protein via TNT-like protrusion
Manish Sharma, Srinivasa Subramaniam
The Journal of Cell Biology (2019) Vol. 218, Iss. 6, pp. 1972-1993
Open Access | Times Cited: 64
Caloric restriction stimulates autophagy in rat cortical neurons through neuropeptide Y and ghrelin receptors activation
Marisa Ferreira‐Marques, Célia A. Aveleira, Sara Carmo‐Silva, et al.
Aging (2016) Vol. 8, Iss. 7, pp. 1470-1484
Open Access | Times Cited: 63
Neuropeptides: Roles and Activities as Metal Chelators in Neurodegenerative Diseases
Shira Ben-Shushan, Yifat Miller
The Journal of Physical Chemistry B (2021) Vol. 125, Iss. 11, pp. 2796-2811
Open Access | Times Cited: 46
The Emerging Role of Neuropeptides in Parkinson’s Disease
Yanan Zheng, Linlin Zhang, Junxia Xie, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 39
Regulation of neuropeptide Y in body microenvironments and its potential application in therapies: a review
Yan Zhang, Chu-Yun Liu, Wei-can Chen, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 39
Neuropeptides and Their Roles in the Cerebellum
Zi-Hao Li, Bin Li, Xiaoyang Zhang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2332-2332
Open Access | Times Cited: 5
Dipeptidyl peptidase-4 inhibitors enhance memory retention via neuropeptide Y
Iulia Zoicas, Stephan von Hörsten, Anne-Christine Plank, et al.
European Journal of Pharmacology (2025), pp. 177556-177556
Open Access
Decreased Peripheral Blood Lymphocytes in Spinocerebellar Ataxia Type 3 Correlate with Disease Severity
Qi Deng, Chen-Yi Tang, Zhao Chen, et al.
Movement Disorders (2025)
Closed Access
Neuroprotective Effects of Neuropeptide Y against Neurodegenerative Disease
Stéphanie Pain, Sébastien Brot, Afsaneh Gaillard
Current Neuropharmacology (2021) Vol. 20, Iss. 9, pp. 1717-1725
Open Access | Times Cited: 27
Cross talk about the role of Neuropeptide Y in CNS disorders and diseases
Rajeshwari Bale, Gaurav Doshi
Neuropeptides (2023) Vol. 102, pp. 102388-102388
Closed Access | Times Cited: 12
Identifying Therapeutic Targets for Spinocerebellar Ataxia Type 3/Machado–Joseph Disease through Integration of Pathological Biomarkers and Therapeutic Strategies
Yu-Shuan Chen, Zhen-Xiang Hong, Shinn‐Zong Lin, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3063-3063
Open Access | Times Cited: 30
Cerebrovascular inflammation: A critical trigger for neurovascular injury?
Muhammad Naveed, Qi‐Gang Zhou, Feng Han
Neurochemistry International (2019) Vol. 126, pp. 165-177
Closed Access | Times Cited: 29
Trehalose alleviates the phenotype of Machado–Joseph disease mouse models
Magda M. Santana, Susana Paixão, Janete Cunha‐Santos, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 25
Current Evidence for a Role of Neuropeptides in the Regulation of Autophagy
Elisabetta Catalani, Clara De Palma, Cristiana Perrotta, et al.
BioMed Research International (2017) Vol. 2017, pp. 1-10
Open Access | Times Cited: 25
Caffeine alleviates progressive motor deficits in a transgenic mouse model of spinocerebellar ataxia
Nélio Gonçalves, Ana Teresa Simões, Rui Daniel Prediger, et al.
Annals of Neurology (2016) Vol. 81, Iss. 3, pp. 407-418
Closed Access | Times Cited: 24
Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease
Oluwaseun Fatoba, Eugen Kloster, Christiane Reick, et al.
Experimental Neurology (2018) Vol. 302, pp. 112-128
Closed Access | Times Cited: 24
Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias
Ricardo Afonso-Reis, Inês T. Afonso, Clévio Nóbrega
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4249-4249
Open Access | Times Cited: 18
Gene Therapies for Polyglutamine Diseases
Carlos A. Matos, Vítor Carmona, Udaya-Geetha Vijayakumar, et al.
Advances in experimental medicine and biology (2018), pp. 395-438
Closed Access | Times Cited: 23
Page 1 - Next Page

Scroll to top